Registration powered by Eventbrite
Contact PCI Pharma for event and ticket information.
Advances Towards Personalized Medicine - Claremont Resort...

Advances Towards Personalized Medicine - Claremont Resort and Spa, Berkeley

Thursday, November 19, 2009 from 8:30 AM to 5:00 PM (PT)

Berkeley, CA


This event has ended!
View current events hosted by PCI Pharma


Ticket Information

Ticket Type Sales End Price Fee Quantity
Full Conference Pass   more info Ended $199.00 $0.00

Event Details

Personalized medicine promises to resolve many problems in drug discovery. Medicines given to heterogenous patient populations may be more effective if the more susceptible individuals are differentiated from non-responders or the hypersensitive. Several tumor subtypes can already be identified and correlated with the optimal therapeutics. This session will provide insights to how and why disease profiling and clinical trials could be done better. We will also explore how existing or new technologies are being applied to map and analyze genetic and tumor types so that treatment protocols can be optimized for the best outcomes.
 

Why you need to go:

The Experimental Man Project: The impact of biomarkers and personalized medicine on patients and consumersDavid Ewing Duncan, Director, Center for Life Science Policy, UC Berkeley

An institute without walls to further collaborations in translational medicine for pediatric cancer
Beth Anne Baber
Co‐Founder, CEO, and President, The Nicholas Conor Institute for Pediatric Cancer Research

The Coming Age of Theranostics
Amit Agarwal, Partner, Scientia Advisors
Changing decision‐making in life sciences & personalized medicine: Applied Semantic Knowledgebases (ASK ®) at work!
Erich A. Gombocz, Vice President, Chief Scientific Officer, IO Informatics

Personalized and Painless: A Non-invasive Disease Detection and Companion Diagnostic Tool
George Schwartz, CEO, DermTech, and
William Wachsman, Associate Professor of Medicine, UC San Diego


Introducing the Genome Commons
Steven Brenner
Principal Investigator of the Genome Commons
Associate Professor at the University of California, Berkeley


Frequency of somatic mutations in human tumors classified by embryonic origin of tissues: identification of developmental lineage‐specific oncogenes and tumor suppressors
Adam Pavlicek, Senior Principal Scientist in Computational Biology, Pfizer


Looking for cancer‐causing genes‐‐tumor vs. host?
David W. Moskowitz, MD, Chairman, Chief Executive Officer and Chief Medical Officer, GenoMed


Point-of-care Personalized Medicine
Ferran Prat
, VP of Oncology and VP of Women’s Health at Inverness Medical Innovations

 
   

When

Thursday, November 19, 2009 from 8:30 AM to 5:00 PM (PT)

Add to my calendar Add to my calendar

Where

Claremont Resort Club and Spa
41 Tunnel Road
Berkeley, CA 94705




Other Maps:



Hosted By

PCI Pharma

A Division of PlanetConnect

With over a 15 Years of experience in Fast-Track Symposia events and over 2000 exhibitor/partners, Fast-Track events have become an accepted standard mechanism for taking the work out of research meetings. From internal corporate R&D meetings of 30 to 2000 to public research events of 50 to 500 scientists, we have helped educate and network the Life Science research community.

View Other Events
View other PCI Pharma events
Contact the Host
Contact the Host
RSS Feed


This event organizer is using Eventbrite to provide
event ticketing and online event registration.
© 2012 Eventbrite. All Rights Reserved. Terms of Service. Privacy Policy.
Contact PCI Pharma for event and ticket information.